PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
2,6-xylidine 201-758-7 87-62-7 - - - - 1 - - - - Details
2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, coupled with 3-aminophenol, diazotized 5-amino-2-[(4-aminophenyl)amino]benzenesulfonic acid and diazotized benzenamine, sodium salts 297-025-4 93281-13-1 - - 1 - 1 - - - - Details
2,7-naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-amino-4,6-dinitrophenol, diazotized 4-nitrobenzenamine and resorcinol, sodium salts
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 34905.
232-380-0 8011-86-7 - - 5 - - - - - - Details
2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-[2-[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-6-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:5) 815-135-8 1386899-40-6 - - - - 1 - - - - Details
2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[[2-[[4-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]sulfonyl]ethyl](2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:6) 943-299-1 - - - - - 1 - - - - Details
2,8,14-trimethyl-5,11-dioxa-2,8,14-triazapentadecane 695-748-3 65286-55-7 - - 2 - - - - - - Details
2,9-bis(2-phenylethyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone 266-564-7 67075-37-0 - - 1 - - - - - - Details
2,9-bis(3,5-dimethylphenyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone 225-590-9 4948-15-6 - - 1 - - - - - - Details
2,9-bis(p-methoxybenzyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone 280-472-4 83524-75-8 - - 1 - - - - - - Details
2,9-bis[4-(phenylazo)phenyl]anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone 221-264-5 3049-71-6 - - 1 - - - - - - Details

Export search results to: